To determine the significance of EGFR and ERBB2 constitutive phosphorylation and KRAS mutant alleles in gallbladder cancer cells, we set out to establish whether expression of ERBB2 is required for gallbladder tumor cell survival. The gene discussed is KRAS; the disease is gallbladder neoplasm.